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Bovine tuberculosis (bTB) is a common zoonotic disease, caused by Mycobacterium bovis (M. 41 
bovis), responsible for significant economic losses worldwide. Its diagnosis is based on the detection 42 
of cell mediated immunity under the exposure to protein purified derivative tuberculin (PPD), a 43 
complex and poorly characterized reagent. The cross-reactivity to non-tuberculous mycobacterium 44 
species (false-positive results) has been crucial to develop a more proper antigen. In the present 45 
study, we selected six M. bovis Open Reading Frames (Mb1992, Mb2031c, Mb2319, Mb2843c, 46 
Mb2845c and Mb3212c) by in-silico analysis and evaluated them in experimental and natural 47 
infection; none of these antigens had been previously assessed as diagnostic antigens for bTB. The 48 
reactivity performance was tested in animals with both positive and negative Tuberculin Skin Test 49 
(TST) results as well as in cattle infected with Mycobacterium avium subesp. paratuberculosis 50 
(MAP). The six recombinant antigens individually induced an IFN-γ response, with overall 51 
responder frequency ranging from 18.3 to 31%. Mb2845c was the most valuable antigen with the 52 
potential to discriminate TST-positive cattle from either TST-negative or MAP infected animals. 53 
Mb2845c showed similar performance to that observed with ESAT-6 and PPD-B among TST and 54 
MTC specific-PCR positive animals, although this reult needs to be proven in further studies with a 55 
higher sample size. Our data confirm the feacibility to implement bioinformatic screening tools and 56 
suggest Mb2845c as a potential diagnostic antigen to be tested in protein cocktails to evaluate their 57 


































1. INTRODUCTION 64 
Mycobacterium bovis (M. bovis) is the etiological agent of bovine tuberculosis (bTB) and a member 65 
of the Mycobacterium tuberculosis complex (MTC), which comprises the causative agents of 66 
tuberculosis (TB) in different animal species [1]. Although cattle are the primary host for M. bovis 67 
infection, wild animals can act as a reservoir. Bovine TB is spread worldwide and, despite the control 68 
efforts and extensive eradication programs based on the test-and-slaughter strategies, remains an 69 
animal health concern in several countries [2,3,4]. Moreover, bTB persists as a zoonotic disease in 70 
certain areas, especially in diary regions [5,6].  71 
The diagnostic test for the control and surveillance of bTB that is used worldwide is the Tuberculin 72 
Skin Test (TST), which is based on the in vivo intradermal inoculation of purified protein derivati e 73 
from M. bovis (PPD-B). An available ancillary test quantifies the in vitro IFN-γ release in a whole 74 
blood culture under PPD-B stimulation (IGRA) [7]. PPD-B has been largely used for bTB diagnosis 75 
as primary diagnostic reagent. However, false-positive reactions can occur because it has 76 
components common to other mycobacterium species such as non tuberculous mycobacteria (NTM) 77 
[8,9,10].  78 
Two immunodominant and specific proteins, ESAT-6 and CFP-10, have been extensively studied. 79 
Both proteins are absent from many NTM and from the M. bovis Bacille Calmette Guerin (BCG) 80 
strain. More recently, Sidders et al. evaluated the us  of Rv3615c in combination with ESAT-6 and 81 
CFP-10 and demonstrated that Rv3615c significantly increased diagnostic sensitivity without 82 
reducing specificity in BCG-vaccinated populations [11]. Other antigens have been assayed alone or 83 
in conjunction with ESAT-6 and CFP-10, in order to s udy possible optimization of bTB diagnosis 84 
[12,13,14]. Furthermore, several studies have been focused in the deciphering of the PPD molecular 85 
composition for the formulation of a more proper antigen cocktail. Thus, proteomic approaches have 86 
led to the identification of approximately 300 protein components [15,16], which represent about 9% 87 
of the total mycobacterium proteome [17].  88 
In the present study we conducted an in silico approach to screen the M. bovis orpheome and thus 89 
search for new and potential candidates, by comparing their performance to a single recombinant 90 
antigen ESAT-6 and the cocktail PPD-B in the in vitro IFN-γ diagnostic test. Six M. bovis 91 
uncharacterized proteins were selected, including Mb1992, Mb2031c, Mb2319, Mb2843c, Mb2845c 92 
and Mb3212c; none of them have been previously identified in PPD-B [15,16]. Our data showed 93 
Mb2845c as the most valuable antigen with the potential to discriminate TST-positive cattle from 94 
















2. MATERIAL AND METHODS 97 
2.1. Ethics Statement 98 
Animal assays were performed inside the biosafety facilities of the National Institute of Agricultural 99 
Technology (INTA), Argentina. This study was carried out under the regulations of the Institutional 100 
Animal Care and Use Committee (CICUAE) of CICVyA-INTA in agreement with the European 101 
Union Laws for protection of experimental animals. Also, these experiments were authorized by 102 
SENASA and the National Consultant Commission of Agricultural Biotechnology (CONABIA). The 103 
ethical approval for this study was obtained from CICUAE (nu 18/2011).  104 
2.2. Cattle population 105 
2.2.1. Experimentally infected animals 106 
Five Holando Argentino calves (three to four months old, males) were experimentally infected with a 107 
wild type M. bovis strain. Details of infection, inoculation and necropsy procedures were previously 108 
described [18]. 109 
2.2.2. Naturally infected animals 110 
Selection of the population was based on the referenc  test for diagnosis of bTB: the Tuberculin Skin 111 
Test (TST). A total of 121 animals of Holando Argentino breed, which were classified in three 112 
groups, were studied. TST-positive animals (n=77) belonged to three bTB infected herds with a 113 
previous history of bTB cases confirmed by microbiological culture and PCR [19]. In the present 114 
study bTB infection was evidenced in TST-positive animals by a MTC-specific PCR (IS6110) in 115 
nasal swabs (n=6) and confirmed by necropsy and microbiological culture in two animals. 116 
The TST-negative group (n=28) included bovines from dairy herds that had been free of bTB for at 117 
least the last five years. A third group of animals with MAP infection, which has been confirmed by 118 
ELISA, cultures (from feces) and PCR [20], was included in this study (n=16). 119 
2.3 Diagnosis 120 
2.3.1. Tuberculin Skin Testing 121 
The caudal fold tuberculin skin test was performed to evaluate M. bovis infection. Animals were 122 
intradermally injected with 0.1 mg of PPD-B (CEVA Santé Animale; Argentina) and the thickness of 123 
the caudal fold was then measured by using calipers b fore and 72 hours after injection. An increase 124 
≥ 5mm in the skin thickness was considered positive, as described by SENASA (Resolution 128/12) 125 















an in-house ELISA [22]. Negative results for MAP serology were considered to include TST-127 
positive and negative samples in the study. 128 
2.3.2. IFN-γ Release Assay (IGRA) 129 
Animals were also screened by IGRA based PPD-B by using a commercial bovine IFN-γ -microplate 130 
enzyme-linked immunosorbent assay (Prionics, Shlieren, Zurich, Switzerland). Whole blood (200µl 131 
aliquots) was dispensed into individual wells in a 96-well plate. IFN-γ release was measured after 132 
stimulation with tested and control antigens. Thus, 4 µg/ml of all tested antigen, sterile PBS 1X, 133 
4µg/ml ESAT-6 (Lionex GmbH, Braunschweig, Germany), 20µg/ml of M. bovis PPD-B, or M. 134 
avium PPD-A (Prionics, Shlieren, Zurich, Switzerland) and 1µg/ml of pokeweed mitogen (Sigma-135 
Aldrich, USA) were used. Blood from six animals with a positive MTC-specific PCR (IS6110) result 136 
were stimulated with PPD-B, PPD-A, ESAT-6, sterile PBS 1X, Mb2845c alone (4, 10 or 20µg/ml), 137 
or in a cocktail with PPD-B (20µg/ml: 1/3 Mb2845c and 2/3 commercial PPD-B). The plasma were 138 
harvested and stored at -80ºC. A result was considered positive if the Optical Density at 450nm 139 
(OD450) with antigens minus the OD450 without antigens was ≥ 0.1. For comparative analysis, a result 140 
was considered positive if the PPD-B OD450 minus the PPD-A OD450 was ≥ 0.1 and the PPD-B OD450 141 
minus the unstimulated control OD450 was ≥ 0.1.  142 
2.3.3. Molecular diagnosis 143 
DNA extraction from nasal swabs was performed as previously described [13] and MTC-specific 144 
PCR (IS6110) was carried out [19].  145 
2.4. Selection of antigens 146 
A computational search was performed by using an integrated bioinformatic comparative tool 147 
(GenoList; www.genolist.pasteur.fr) [23] to identify specific genes from MTC. A reference list was 148 
generated, including M. bovis strains AF2122/97, BCG and Pasteur 1173P2 and M. tuberculosis 149 
strains CDC1521, H37Ra and H37Rv. An additional query list included Mycobacterium genomes 150 
outside the MTC: M. abscessus strain ATCC 19977, M. avium strain 104, M. gilvum strain PYR-151 
GCK, M. leprae strain TN, M. marinum strain M, M. paratuberculosis strain K-10, M. smegmatis 152 
strain MC2 155, M. ulcerans strain agy99 and M. vanbaalenii strain PYR-1. A cut-off value of 90% 153 
selection and 15% of exclusion were used. A blast search was performed with the selected ORFs 154 
(www.ncbi.nlm.nih.gov/BLAST) to exclude those present in other organisms. The selected 155 
candidates were then analyzed by using sets of overlapping peptides with the NetMHCII 2.2 Server 156 
(www.cbs.dtu.dk/services/NetMHCII) in the context of the BoLA class II molecule. The median 157 















immunogenicity. The molecular weight of the selected ORFs was predicted by using Uniprot 159 
(http://www.uniprot.org/). 160 
2.5. Bacterial growth and DNA isolation  161 
The M. bovis AN5 strain was grown in Dorset-Henley medium for 28 days at 37ºC and harvested by 162 
centrifugation. The DNA was extracted [24] and used as template to amplify and then clone the 163 
selected ORFs. 164 
2.6. Cloning, expression and purification of the recombinant antigens 165 
The gene sequences were amplified with Pfx DNA polymerase (Invitrogen), cloned into a 166 
pENTR™/D-TOPO® vector and sub-cloned in the pDEST17 vector (Gateway System, Invitrogen). 167 
The recombinant proteins tagged with histidine (Hisx6) were expressed in chemically competent 168 
BL21-AI Escherichia coli cells (Invitrogen) and recovered from inclusion bodies. The induced 169 
bacterial culture (200ml) was harvested by centrifugation and resuspended in 4 ml of lysis buffer (50 170 
mM Tris-HCL pH8.0, 100 mM NaCl, 0.5% Triton X-100) by sonication (4ºC, 3 min, 1 second 171 
interval, output 5). DNAse (0.01 mg/ml) and Lysozyme (0.1 mg/ml) were added at room temperature 172 
(20 minutes) and subsequently centrifugation was performed (4500g, 15 minutes, 4ºC). The pellet 173 
was resuspended in lysis buffer and sonication and ce trifugation was performed as above. Inclusion 174 
bodies were resuspended in 4ml of wash buffer (50m M Tris-HCL pH8.0, 100 mM NaCl), 175 
centrifuged (4500g, 15 minutes, 4ºC) and resuspended in 500 µl of wash buffer with sonication (10 176 
seconds). Suspension was dissolved drop wise into urea 8M and the supernatant was recovered at 177 
maximum speed centrifugation. Proteins were purified by affinity chromatography on an Agarose-178 
Nickel column (Qiagen) under denaturing conditions following the manufacturer’s instructions. 179 
Dialysis was performed (molecularporous membrane Spctra/Por) in stirring urea 4M, 2M, 1M, 180 
0.5M and 0.25M solution at 4ºC. A final dialysis step was carried out at 4ºC overnight in stirring 181 
fresh PBS 1X buffer. Proteins were quantified by Bradford protein assay (BioRad).   182 
2.7. SDS-PAGE Coomassie blue staining and Western Blot analysis 183 
Protein expression was confirmed by Coommassie blue stained polyacrylamide gel and Western blot 184 
assay. Blots were probed with a mouse anti-his monocl al antibody (GE) at a 1:3000 dilution. As a 185 
secondary antibody, alkaline phosphatase-conjugated nti-mouse immunoglobulin G (Sigma) was 186 
used at a dilution of 1:30,000. For detection, BCIP/NBT colour development substrates (Promega, 187 
















2.8.  Statistical analysis 190 
 Responder frequencies for every antigen; including PPD-B and PPD-A, were calculated as the 191 
percentage of animals in which the OD450 antigen mius the OD450 nil was ≥ 0.1. Statistical 192 
comparison and frequencies were performed with EpiDat 3.0 version software (Xunta de Galicia, 193 
OPS-OMS). Statistical difference in the magnitude response (∆OD450) between those induced by 194 
control and tested antigens was determined by using ANOVA. P values computed ≤ 0.05 were 195 
reported as measures of statistical significance. Graphics were constructed by using GraphPad prism 196 
















3. RESULTS  199 
3.1. Selection of antigens 200 
Fifteen completely sequenced Mycobacterium genomes were analyzed comparatively. A total of 44 201 
ORFs specific to MTC members were identified. Nine of these ORFs were excluded for sharing 202 
similarity to M. kansasii proteins, thus resulting in a final selected group f 35 ORFs.  203 
The median affinity constant in terms of immunogenicity was calculated based on the identification 204 
of peptide binding core motifs in the full linear aminoacid sequence. Seven ORFs (Mb1753c, 205 
Mb1979c, Mb1990, Mb2749, Mb2851c, Mb3135 and Mb3458c) did not show any antigenic 206 
determinant. Therefore, the final candidate group comprised 28 ORFs: Mb0061, Mb0613c, 207 
Mb0627c, Mb0629, Mb1015, Mb1024, Mb1077c, Mb1401, Mb1700c, Mb1764c, Mb1992, 208 
Mb2031c, Mb2039, Mb2049c, Mb2166c, Mb2298, Mb2317, Mb2319, Mb2627, Mb2842c, 209 
Mb2843c, Mb2844c, Mb2845c, Mb2847c, Mb2848c, Mb3212c, Mb3412c and Mb3558c. Their 210 
sequences exhibited an amino acid homology ranging from 99.2 to 100% with their orthologous 211 
proteins in M. tuberculosis. 212 
Six candidates were selected for further analysis (Mb1992, Mb2031c, Mb2319, Mb2843c, Mb2845c 213 
and Mb3212c) because they exhibited the highest predicted immune score. All proteins differed in 214 
the number of predicted immunological epitopes in decreasing order as follows: Mb3212c, 215 
Mb2031c, Mb1992, Mb2319, Mb2843c and Mb2845c (Table 1). 216 
3.2. Reactivity of the recombinant candidates in experimentally infected cattle 217 
The selected candidates were first studied by analyzing the blood from five experimentally infected 218 
calves with confirmed M. bovis infection by necropsy and microbiological culture for M. bovis. 219 
Mb1992 and Mb2845c antigens induced IFN-γ release in the five animals. Mb2319 exhibited a 220 
positive response in three out of five infected animals, whereas Mb3212c stimulated IFN-γ release 221 
only in one animal. Mb2031c and Mb2843c did not induce IFN-γ release in any of the blood 222 
samples. In all cases, PPD-B elicited a higher respon e than the recombinant proteins followed by 223 
ESAT-6. We also analyzed the reactivity under stimulation with PPD-A (Figure 1).  224 
3.3. Reactivity of the recombinant candidates in naturally infected cattle 225 
IGRA based PPD-B was carried out in order to classify the studied animals as bTB positive or 226 
negative by an ancillary diagnostic test (Bovigam, Prionics). A total of 77 TST-positive animals were 227 
evaluated, of which 66% (51/77) were positive and 34% (26/77) resulted negative. To compare the 228 
antigenic performance between the PPD-B, PPD-A, ESAT-6 and the six proteins codified by the 229 
selected M. bovis ORFs, we tested their individual ability to stimulate IFN-γ release in 71 TST-230 















0.05) and statistically lower than the responder frquency obtained with PPD-B (p < 0.0001): 232 
Mb2319 (31%), Mb1992 (29.5%), Mb3212c (25%), Mb2031c and Mb2843c (24%), and Mb2845c 233 
(18.3%) in the TST-positive group (Figure 2). The magnitude of the IFN-γ response for each antigen 234 
is shown in supplementary material (Figure 1, Supplementary Data). 235 
The M. bovis infection was confirmed in two animals (by necropsy and microbiological culture): one 236 
of them with reactivity to ESAT-6, and the other animal exhibited reactivity to ESAT-6, Mb2319 and 237 
Mb3212 (tested individually).  238 
Then, the analysis was focused on the IGRA based PPD-B nonreactive samples (n=24), which were 239 
named as “discordant” because they showed a positive TST and a negative IGRA based PPD-B 240 
result. Twelve discordant samples were positive by IGRA under the stimulation of the individual 241 
recombinant candidates’, six of them in conjunction t  ESAT-6 and the remaining six samples only 242 
under stimulation with the uncharacterized antigens. A variable reactivity pattern was observed, thus 243 
suggesting differences in the abilities of the animals’ immune systems to recognize antigens (Table 244 
2).  245 
Of the total TST-positive samples (n=77), 44 (57%) showed a positive IFN-γ release under ESAT-6 246 
stimulation, whereas 33 (43%) remained negative. The proportion of reactors under ESAT-6 247 
stimulation was significantly higher than the one obtained with the uncharacterized antigens (p < 248 
0.0005). However, among the ESAT-6 negative samples, a l the recombinant antigens induced IFN-γ 249 
release in different, but not significant (p > 0.05), proportions (Data not shown). Most of these 250 
ESAT-6 non reactive samples were negative under PPD-B stimulation by IGRA.  251 
M. bovis diagnosis investigation underlies the discovery of new diagnostic reagents in order to 252 
discriminate between a real infection (caused by M. bovis) and other infections (caused by MNT 253 
species). For this purpose, the reactivity of recombinant candidates was further studied in MAP 254 
infected cattle. The individual recombinant candidates, with the exception of Mb2845c, showed a 255 
positive response by IGRA under single antigen stimulation as follows: Mb1992 (1/16), Mb2031c 256 
(1/16), Mb2319 (5/16), Mb2843 (1/16) and Mb3212c (1/16).  257 
With the samples from TST-negative cattle, Mb2845c did not induce a positive response by IGRA as 258 
well as Mb2031c and Mb3212c, whereas the remaining a tigens induced IFN-γ release in a few 259 
animals (Figure 2). Our data suggest Mb2845c as the most relevant protein with the potentiality to 260 
avoid a possible false-positive IGRA result. 261 
A group of six animals with TST and MTC-specific PCR positive results was studied in order to 262 
evaluate the antigen Mb2845c. A responder frequency of 50% (3/6) was observed for Mb2845c 263 
either alone (at 10µg/ml and 20µg/ml, with no positive reactors at 4µg/ml) or in a protein cocktail 264 















(83.3%, p = 0.54) and for the PPD-B cocktail (66.7%, p=1). It is interesting to note that one of the 266 
Mb2845c positive animal; also positive with ESAT-6, exhibited a discordant result for PPD-B (TST 267 
















4. CONCLUSIONS 270 
In this study we identified six specific Mycobacterium bovis proteins by bioinformatics comparisons 271 
of the genomes of different mycobacteria and by prediction of binding to the BoLA class II 272 
molecule. None of the analyzed proteins has been prviously tested for the diagnosis of bTB in 273 
cattle.   274 
The bioinformatics screening tool implemented in this study led to the selection of uncharacterized 275 
M. bovis ORFs whose proteins exhibited immunogenic reactivity in experimental and natural bTB 276 
conditions.   277 
The criteria established in the in silico search to select ORFs exclusive to members of the 278 
Mycobacterium tuberculosis Complex was confirmed with previously published data bout on 279 
orthologous genes in M. tuberculosis. 280 
In spite of the search criteria used here, Mb1992, Mb2031c, Mb2319, Mb2843c and Mb3212c 281 
exhibited reactivity in TST-negative and/or MAP-infected cattle; which suggests cross-reactivity 282 
between these uncharacterized antigens and those in NTM species.  283 
A highest performance for PPD-B and the single recombinant ESAT-6 antigen in comparison to the 284 
tested candidates was confirmed.   285 
The results obtained in experimental and natural infected animals suggest to Mb2845c as a valuable 286 
protein for diagnostic testing that need to be further explored in order to characterize 287 
sensitivity/specificity as well as the optimal cut-off associated to this recombinant antigen, either 288 
















5.    DISCUSSION 291 
In the present study, six uncharacterized M. bovis proteins were assayed by the IGRA in their ability 292 
to induce IFN-γ release in experimental and natural M. bovis infection. Although the six candidates 293 
were not previously tested as diagnostic antigens, published data on their orthologous genes in M. 294 
tuberculosis support the bioinformatics selection. For instance, Rv2819c (Mb2843c ortholog) is 295 
specific to the M. tuberculosis complex species [25], whereas Mb2843c and Mb2845c exhibit 100% 296 
homology to CRISPR-associated proteins Csm5 (Rv2819c) and Cmr4 (Rv2821c), only described in 297 
M. tuberculosis and M. bovis [26].  298 
PPD-B has been the most widely used reagent for bTB diagnosis [27]. However, the description of 299 
specific reagents provided evidences about the usefulness and advantages to use a more proper 300 
antigenic cocktail to avoid non-specific reactors [8,9,10]. MAP and other non-pathogenic 301 
mycobacterium infections have been pointed out as a cause of cross-reactivity reactions. In a 302 
previous study, the authors reported higher IFN-γ responses for PPD-A than for PPD-B in TST-303 
negative animals from Northern Ireland, Mexico and Argentina, and concluded that this result 304 
suggest an exposure to environmental mycobacterials [10]. Similarly, our data showed a median 305 
OD450 for PPD-A higher than for PPD-B in the TST-negative group, although these values were not 306 
significantly different (p > 0.05).  307 
Mb1992, Mb2319 and Mb2843c induced reactivity in some TST negative cattle. Considering the 308 
negativity for MAP serology of these animals, the results could be explained by a possible non-309 
pathogenic environmental mycobacterium infection that would induce an immune cross-reactivity 310 
with the recombinant antigens. Some samples from the MAP group reacted to Mb1992, Mb2031c, 311 
Mb2319, Mb2843 and Mb3212c stimulation (positive response by IGRA). Accordingly, these data 312 
suggest that five out of six tested proteins may share epitopes with NTM species in spite of the 313 
specificity of the bioinformatics selection criteria. Nevertheless, it offers a useful tool for short-te m 314 
results at a low cost, especially when the input to be analyzed is as vast as the M. bovis orpheome 315 
[17]. 316 
Previous studies showed ESAT-6 responder frequency ranging from 66% to 78% in European cattle 317 
herds. In our country, a 78% of reactors were described in high prevalence bTB herds [10]. Although 318 
in the present study a lower responder frequency out of the reported interval was obtained for ESAT-319 
6 (57%), the frequency was similar to those previously described (p=0.056). Thus, the different 320 
proportions observed in the studied regions could be attributed to factors such as variation in 321 















Rv3615c has been shown as an antigen that did not overlap ESAT-6/CFP-10 immune reactivity in 323 
the IGRA and thus a potential candidate to increase ESAT-6/CFP-10 cocktail sensitivity in naturally 324 
infected cattle [11,28,29]. In this study, among all tested proteins, Mb2845c seemed to be the most 325 
promising antigen, with the potential to avoid cross reactivity with NTM species. However, in 326 
contrast to Rv3615, Mb2845c response overlapped the ESAT-6 reactivity. with the exception of a 327 
discordant sample that only reacted upon Mb2845c stimulation.  328 
In the case of Mb1992 the immune reactivity observed in the bovine host, either in the experimental 329 
or natural M. bovis infection, confirmed its cell mediated inducer nature, which has been previously 330 
described for its ortholog in M. tuberculosis Rv1957 (which shares 100% homology with Mb1992), 331 
in humans. However, in contrast to that for the current study where the Mb1992 responder frequency 332 
was significantly lower than that for ESAT-6, the study in humans showed that the response for 333 
Rv1957 was similar to that for ESAT-6 [30]. 334 
A thirth of the TST-positive samples showed a PPD-B based discordant result (TST positive/ IGRA 335 
negative). This pattern was also detected in two out of the six positive animals for MTC-specific 336 
IS6110 PCR. Although PCR is not considered a “gold standard” technique, it represents an evidence 337 
of infection and thus this result supports the idea that these two discordant animals would be infected 338 
but no reactors to the in vitro diagnostic test. Furthermore, it was reported thate sensitivity of the 339 
in vitro IFN-γ test may be reduced with extended periods from blood collection to culture [31]. In the 340 
present study, the TST-positive samples were collected from two different geographical areas and 341 
samples differed in the time period from collection t  culture. However, OD450 PKW mitogen was 342 
similar in these two groups (p > 0.05) (Figure 2, Supplementary data). This finding suggests that 343 
PBMC viability would not be the reason for the discordance observed.  344 
Frequently, evaluations of diagnostic antigens are accompanied by statistical tests such as receiving 345 
operating curves (ROC) to estimate their performance. Indeed, samples should be assessed by the 346 
accepted ‘gold standard’ to confirm infection/disea (culture of M. bovis from tissues or visible 347 
lesions). Considering that only two animals included in the current study were slaughtered, ROC was 348 
not used to statistically evaluate the performance of r combinant candidates.  349 
Mb2845c was the most valuable antigen because did not induce a positive IFN-γ release neither in 350 
TST-negative nor MAP groups. Results obtained in experimental and natural infected animals 351 
suggest that this antigen has properties that need to be further explored in order to characterize 352 
sensitivity/specificity as well as the optimal cut-off associated to this recombinant antigen, either 353 
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Table 1. Predicted epitopes in the selected candidates in the context of Bovine 




















Mb2031c Rv2008c 1332 7 ITIDEAQRI 6.3 48.4 




Mb2319 Rv2297 457 7 VRCDNPTLM 10 16.5 
Mb2843c Rv2819c 1134 6 VKLDPAKHR 23.2 42.3 


















Table 2. Reactivity patterns obtained for discordant samples showing that showed 
a positive IGRA upon stimulation with the recombinant candidates (n=12).   
Mb1992 Mb2031c Mb2319 Mb2843c Mb2845c Mb3212c ESAT-6 
      X* 
X  X X X X X 
    X X X 
X   X X X X 
X X X X X X X 
     X  
    X   
   X    
 X      
  X     
X X X   X  
 














































































Figure 2. Responder frequencies observed with tested and control (PPD-B, PPD-A 







































CAPTIONS TO ILLUSTRATIONS 1 
Title Table 1. Predicted epitopes in the selected candidates in the context of the Bovine 2 
Leucocyte Antigen (BoLA) type II.  3 
Legend Table 1. The selected ORFs were screened to analyze the presnce of epitopes and predict 4 
the immunological affinity to the BoLA class II molecule. Number of predicted peptide cores and the 5 
median affinity constant value (nM) for each ORF are shown. Molecular weight of each predicted 6 
protein was calculated by using Uniprot database.  7 
Title Figure 1. In vitro evaluation of single recombinant antigens in experimentally infected 8 
cattle. 9 
Legend Figure 1. Five calves were experimentally infected with the M. bovis 04-M303 strain and 10 
further screened (100 days post infection) to evaluate the IFN-γ release under stimulation with tested 11 
and control antigens by ELISA (Bovigam, Prionics). Data are shown as ∆OD450 (OD450 antigen 12 
minus OD450 nil). The horizontal line provides the m an (±SEM). Cut-off for positivity is indicated 13 
by dashed lines (∆OD450 ≥ 0.1). Note that scale for Y axis differs for tested (Mb1992, Mb2031c, 14 
Mb2319, Mb2843c, Mb2845c and Mb3212c) and control antigens (PPD-B, PPD-A and ESAT-6). 15 
Statistical difference between responses induced by the tested antigens was determined by using 16 
ANOVA (*, p < 0.05). 17 
Title Figure 2. Responder frequencies observed with tested and control (PPD-B, PPD-A and 18 
ESAT-6) antigens by the IGRA in the TST-positive, TST-negative and MAP-infected animals. 19 
Legend Figure 2. 20 
Six in silico selected antigens were screened in their ability to induce IFN-γ release in blood samples 21 
from TST-positive (TST+; n=71), TST-negative (TST-; n=28) and MAP-infected animals (MAP; 22 
n=16) by ELISA (Bovigam, Prionics). Responder frequncies for every antigen; including PPD-B, 23 
PPD-A and ESAT-6, were calculated as the percentage of animals in which the subtraction of 24 
OD450 antigen and OD450 nil was ≥ 0.1 for each studied group. PPD-B, PPD-A and ESAT-6 were 25 
included as reference antigens. 26 
 27 
Title Table 2. Reactivity patterns obtained among discordant samples that showed a positive 28 
IGRA under the stimulation of the recombinant candidates.    29 
Legend table 2.  30 
Reactivity of 12 discordant samples (TST-positive/IGRA-PPDB negative) by IGRA after individual 31 















reactivity against the recombinant antigens but not under stimulation with ESAT-6. X denotes a 33 
positive response with the specified antigen.   34 
 35 
Title Supplementary Figure 1. Magnitud of the IFN-γ response for each tested and control 36 
antigens in the TST-positive, TST-negative and MAP infected animals.  37 
 38 
Legend Supplementary Figure 1.  39 
The in vitro capacity of the tested antigens (4 µg/ml) to induce IFN-γ was determined in blood from 40 
the three groups analyzed: TST-positive (TST+; n=71), TST-negative (TST-; n=28) and MAP 41 
infected animals (MAP; n=16 ). The responses induce by ESAT-6 (4 µg/ml), PPD-B or PPD-A (20 42 
µg/ml) were also studied. The ∆OD450 (OD450 antigen minus OD450 nil) is represented by black 43 
circles for each animal. The horizontal line provides the mean and the standard error of the mean 44 
(SEM). A thereshold equal to ∆OD450 = 0.1 is shown for every antigen as an horizontal dashed 45 
lines.   46 
Title Supplementary Figure 2. IFN-γ release upon Pokewed mitogen stimulation in all the 47 
samples analyzed. 48 
Legend Supplementary Figure 2. 49 
To examine if cell viability could be influenced bydifferent periods from blood collection to culture, 50 
all samples were tested by IFN-γ realease upon a mitogen stimulation (1 µg/ml). TST-positive 51 
samples differed in the period from blood collection t  culture: two fields were located to 8 hours 52 
(TST+ “far”, n=65) from the lab and the other to 3 hours (TST+ “near”, n=12) from the lab.  TST-53 
negative animals (TST-; n=28), MAP infected cattle (MAP; n=16) and experimentally infected cattle 54 
(EIC; n=5) were also included. The median ∆OD450 (OD450 PKW minus OD450 nil) is represented 55 
by bars. One way anova was used to statistically compare all groups, showing no differences among 56 













Supplementary Figure 1. Magnitud of the IFN-γ response for each tested and control 1 
antigens in the TST-positive, TST-negative and MAP infected animals.  2 
Mb1992











































































































































Supplementary Figure 2. IFN-γ release upon Pokewed mitogen stimulation in all the samples 
analyzed. 
 
 
PKW
TS
T-
TS
T 
+ 
(fa
r)
TS
T+
 (n
ea
r)
MA
P
EI
C
0
1
2
3
4
∆∆ ∆∆
O
D
45
0
